You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
The researcher's observations were published in the October 2000 issue of the Journal of Pain and Symptom Management. Recent research has demonstrated the effectiveness and safety of gabapentin for the treatment of painful diabetic neuropathy.
For the 12-week trial, 13 patients were randomized to receive gabapentin and 12 were treated with amitriptyline. The gabapentin dose began at 400 mg per day and was titrated up to 2400 mg per day over four weeks. During the same time frame, amitriptyline began at 10 mg per day and was titrated up to 90 mg per day.
A similar number of patients in each group achieved a pain score of one or less, but in three patients taking gabapentin pain was completely eliminated. Nobody taking amitriptyline achieved this level of pain reduction.
Adverse effects were less common in the gabapentin group than in the amitriptyline group, occurring in four and 11 patients, respectively.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.